Since the first antiviral drug, idoxuridine, was approved in 1963, 90 antiviral drugs
categorized into 13 functional groups have been formally approved for the treatment of the …

Human Papillomavirus (HPV) research has been dominated by the study of a subset of
Alpha papillomaviruses that together cause almost 5% of human cancers worldwide, with …

Human papillomavirus (HPV) infection is causally associated with benign and malignant
diseases of the upper airway, including respiratory papillomatosis and oropharyngeal …

Perhaps one of the most important developments in head and neck oncology of the past
decade is the demonstration that patients with human papillomavirus (HPV)-mediated …

Although recurrent respiratory papillomatosis is a benign disease of the upper aerodigestive
tract caused by infection with human papillomavirus, the disease process is unpredictable …

Objectives Recurrent respiratory papillomatosis (RRP) is a chronic disease of the respiratory
tract that occurs in both children and adults. It is caused by the human papillomavirus (HPV) …

Infection with human papillomavirus (HPV) is almost universal and eventually asymptomatic,
but pathologic infection with HPV is severe, recurrent, and recalcitrant to therapy. It is also an …

Juvenile-onset recurrent respiratory papillomatosis (JRRP) is a rare and debilitating
childhood disease that presents with recurrent growth of papillomas in the upper airway …

Squamous cell papilloma (SCP) in the upper aero-digestive tract is a rare disease entity with
bimodal age presentation both at childhood and in adults. It originates from stratified …

Human papillomavirus (HPV) infections cause a significant global health burden,
predominantly due to HPV-associated cancers. HPV infects only the epidermal cells of …